5-[4'-(Bromomethyl)-1,1'-biphenyl-2-yl]-1-triphenylmethyl-1H-tetrazole , 96% , 124750-51-2

CAS NO.：124750-51-2

Empirical Formula: C33H25BrN4

Molecular Weight: 557.48

MDL number: MFCD00665221

EINECS: 603-010-9

PRODUCT Properties

• Melting point: 152-155°C
• Boiling point: 61°C/12mmHg(lit.)
• Density: 1.28±0.1 g/cm3(Predicted)
• storage temp.: Inert atmosphere,2-8°C
• solubility: Soluble in Chloroform and Methanol (Sparingly)
• form: Solid
• pka: 0.29±0.10(Predicted)
• color: White
• Stability: Moisture Sensitive
• InChI: InChI=1S/C33H25BrN4/c34-24-25-20-22-26(23-21-25)30-18-10-11-19-31(30)32-35-36-37-38(32)33(27-12-4-1-5-13-27,28-14-6-2-7-15-28)29-16-8-3-9-17-29/h1-23H,24H2
• InChIKey: ZTFVTXDWDFIQEU-UHFFFAOYSA-N
• SMILES: N1(C(C2=CC=CC=C2)(C2=CC=CC=C2)C2=CC=CC=C2)C(C2=CC=CC=C2C2=CC=C(CBr)C=C2)=NN=N1
• CAS DataBase Reference: 124750-51-2(CAS DataBase Reference)

Description and Uses

5-[4′-Bromomethyl-(1,1′-biphenyl)-2-yl]-1-triphenylmethyltetrazole is an intermediate in the synthesis of Losartan and Valsartan. Utilized for various purposes, 5-[4′-Bromomethyl-(1,1′-biphenyl)-2-yl]-1-triphenylmethyltetrazole has found application as a fluorescent probe to identify DNA damage. It serves as a photosensitizer in photodynamic therapy and acts as a catalyst in polymer synthesis. Furthermore, this compound functions as a fluorescent label to detect proteins and as a fluorescent indicator to detect metal ions.

Used as Olmesartan medoxomil related intermediate, Olmesartan medoxomil is an angiotensin II receptor antagonist^[1]. 

Safety

• Symbol(GHS): GHS02,GHS07
• Signal word: Danger
• Hazard statements: H315-H319-H228
• Precautionary statements: P240-P210-P241-P264-P280-P302+P352-P370+P378-P337+P313-P305+P351+P338-P362+P364-P332+P313
• RIDADR: UN 2811 6.1/PG III
• HazardClass: 6.1
• PackingGroup: III
• REACH Registrations: Active
• Limited Quantities: 5.0 Kg (11 lbs) (solid)
• Excepted Quantities: Max Inner Pack (30g or 30ml) and Max Outer Pack (1Kg or 1L)